A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer.
第一作者:
Amy,Hawarden
第一单位:
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, United Kingdom.;Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Level 5, Research, Manchester, United Kingdom.
作者:
医学主题词
人类(Humans);女(雌)性(Female);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);蛋白质类(Proteins);治疗结果(Treatment Outcome)
DOI
10.1371/journal.pone.0281798
PMID
36952534
发布时间
2023-04-18
- 浏览0
PloS one
e0281798页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



